HOFFMAN ROBERT 4
4 · Kintara Therapeutics, Inc. · Filed Nov 10, 2021
Insider Transaction Report
Form 4
Hoffman Robert E.
Director
Transactions
- Award
Options (Right to Buy)
2021-11-08+3,519,170→ 3,519,170 totalExercise: $0.96Exp: 2031-11-08→ Common Stock (3,519,170 underlying)
Footnotes (1)
- [F1]The option award was made to the reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to the reporting person's continued employment, the shares subject to the option shall vest as follows: 25% of the shares subject to the option shall vest on November 8, 2022, and the remainder shall vest in equal monthly installments over the following thirty-six (36) months.